▁Bre 10.375
ast 6.7890625
▁cancer 7.6953125
▁is 6.73828125
▁a 1.78515625
▁topic 5.74609375
▁that 2.572265625
▁has 2.93359375
▁been 1.361328125
▁widely 4.6875
▁discussed 2.1015625
▁in 1.7021484375
▁recent 3.255859375
▁years 1.6845703125
▁due 7.2890625
▁to 0.17041015625
▁its 3.748046875
▁increasing 6.6640625
▁pre 5.109375
val 2.162109375
ence 0.1185302734375
▁in 2.474609375
▁society 5.0
. 1.8349609375
▁Many 5.58203125
▁factors 5.17578125
▁contribute 2.841796875
▁to 0.1961669921875
▁the 1.4296875
▁development 3.076171875
▁of 0.21240234375
▁breast 2.591796875
▁cancer 0.1097412109375
, 1.123046875
▁including 1.505859375
▁her 2.85546875
ed 0.443115234375
ity 0.0133209228515625
, 0.41259765625
▁dise 9.046875
ases 0.0057525634765625
▁of 2.87890625
▁the 0.481201171875
▁m 5.421875
amm 0.07244873046875
ary 0.0007076263427734375
▁g 0.29638671875
lands 1.1474609375
, 0.38525390625
▁and 1.9462890625
▁h 2.9921875
orm 0.0058746337890625
onal 0.195068359375
▁factors 1.81640625
. 0.42822265625
<0x0A> 1.7861328125
H 3.763671875
ered 1.5810546875
ity 0.01071929931640625
▁is 1.63671875
▁a 1.30859375
▁critical 5.7265625
▁factor 0.6103515625
▁in 0.423583984375
▁the 0.44775390625
▁development 0.23779296875
▁of 0.047821044921875
▁breast 0.248046875
▁cancer 0.01366424560546875
. 0.583984375
▁If 4.5625
▁a 0.80712890625
▁person 1.546875
▁has 0.6982421875
▁a 0.22412109375
▁family 0.8544921875
▁history 0.11090087890625
▁of 0.0225830078125
▁breast 0.1376953125
▁cancer 0.0222930908203125
, 0.1358642578125
▁their 3.6015625
▁ch 1.8291015625
ances 0.0002359151840209961
▁of 0.0670166015625
▁developing 0.272705078125
▁the 0.63427734375
▁disease 0.06842041015625
▁increase 2.34765625
▁significantly 2.09375
. 0.09033203125
▁This 1.669921875
▁is 0.53759765625
▁because 0.79296875
▁certain 3.76171875
▁gen 0.29345703125
es 0.1640625
, 2.640625
▁such 1.47265625
▁as 0.0013580322265625
▁BR 0.389892578125
CA 0.0055389404296875
1 0.425537109375
▁and 0.1917724609375
▁BR 0.0316162109375
CA 0.006336212158203125
2 0.01275634765625
, 0.0305328369140625
▁are 0.72705078125
▁responsible 3.03515625
▁for 0.0007295608520507812
▁suppress 7.41796875
ing 0.0011510848999023438
▁tum 2.216796875
or 0.11187744140625
▁growth 0.89208984375
. 0.99658203125
▁When 3.80078125
▁these 1.279296875
▁gen 0.04437255859375
es 0.00379180908203125
▁are 0.1568603515625
▁mut 0.74755859375
ated 0.000629425048828125
, 0.1873779296875
▁they 1.041015625
▁are 2.341796875
▁no 1.0048828125
▁longer 0.0008249282836914062
▁able 0.52490234375
▁to 0.001232147216796875
▁do 1.4091796875
▁their 0.426513671875
▁job 0.12432861328125
▁effectively 3.380859375
, 0.72607421875
▁leading 1.693359375
▁to 0.004161834716796875
▁an 2.18359375
▁increased 0.54248046875
▁risk 0.1361083984375
▁of 0.032562255859375
▁breast 0.7958984375
▁cancer 0.01371002197265625
. 0.26708984375
<0x0A> 0.444580078125
D 0.79931640625
ise 0.01442718505859375
ases 0.01297760009765625
▁of 0.02239990234375
▁the 0.01074981689453125
▁m 0.20068359375
amm 0.0015850067138671875
ary 0.00023055076599121094
▁g 0.002593994140625
lands 0.0284271240234375
▁also 3.115234375
▁play 0.35693359375
▁a 0.09552001953125
▁role 0.168212890625
▁in 0.007205963134765625
▁the 0.06756591796875
▁development 0.0157928466796875
▁of 0.006916046142578125
▁breast 0.01326751708984375
▁cancer 0.0016870498657226562
. 0.0259246826171875
▁Cond 4.41015625
itions 0.00505828857421875
▁such 0.2000732421875
▁as 0.0002238750457763672
▁at 5.59765625
yp 0.301513671875
ical 0.0283203125
▁hyper 0.1483154296875
pl 0.0244903564453125
asia 0.005126953125
▁and 0.98388671875
▁lo 2.9765625
b 0.0038089752197265625
ular 0.0013866424560546875
▁car 0.28369140625
cin 0.00012791156768798828
oma 0.0015821456909179688
▁in 0.0330810546875
▁situ 0.035247802734375
▁are 1.724609375
▁known 2.662109375
▁to 0.02911376953125
▁increase 0.7236328125
▁the 0.64501953125
▁risk 0.150390625
▁of 0.00952911376953125
▁developing 0.60791015625
▁breast 0.252197265625
▁cancer 0.003932952880859375
. 0.329833984375
▁These 0.9228515625
▁dise 3.0234375
ases 0.00018918514251708984
▁cause 3.97265625
▁ab 1.8125
normal 0.003566741943359375
▁growth 0.591796875
▁of 0.364013671875
▁cells 1.2646484375
▁within 2.607421875
▁the 0.0177459716796875
▁breast 0.89599609375
▁t 1.3681640625
issue 0.034210205078125
, 0.22265625
▁which 0.533203125
▁can 0.40087890625
▁eventually 2.091796875
▁lead 0.447265625
▁to 7.271766662597656e-05
▁the 1.31640625
▁formation 1.6767578125
▁of 0.0012598037719726562
▁tum 0.70263671875
ors 0.033782958984375
. 0.03778076171875
<0x0A> 0.16064453125
H 0.82958984375
orm 7.641315460205078e-05
onal 0.02838134765625
▁factors 0.00817108154296875
▁are 0.880859375
▁another 2.431640625
▁critical 2.068359375
▁factor 0.060791015625
▁in 0.03619384765625
▁the 0.0136566162109375
▁development 0.0017719268798828125
▁of 0.0017290115356445312
▁breast 0.0016469955444335938
▁cancer 0.0003216266632080078
. 0.00936126708984375
▁Est 3.375
ro 0.1883544921875
gen 3.147125244140625e-05
, 1.7470703125
▁a 1.333984375
▁h 0.230224609375
orm 3.5762786865234375e-07
one 0.001224517822265625
▁produced 0.65185546875
▁in 4.1484375
▁the 0.1529541015625
▁o 0.380126953125
var 0.00024437904357910156
ies 0.0015392303466796875
, 0.1959228515625
▁has 3.462890625
▁been 0.358642578125
▁linked 1.4716796875
▁to 0.01776123046875
▁the 0.74365234375
▁growth 4.31640625
▁of 0.334716796875
▁breast 0.4619140625
▁cancer 0.5361328125
▁cells 0.371337890625
. 0.1490478515625
▁Women 3.400390625
▁who 0.141357421875
▁have 0.9755859375
▁higher 4.94921875
▁levels 0.26611328125
▁of 0.000762939453125
▁est 0.1595458984375
ro 0.016265869140625
gen 1.8358230590820312e-05
▁in 0.133544921875
▁their 0.01403045654296875
▁bodies 1.345703125
, 3.658203125
▁either 3.26171875
▁naturally 1.3525390625
▁or 0.0712890625
▁through 0.75244140625
▁h 0.5732421875
orm 0.0010442733764648438
one 0.038726806640625
▁replacement 0.16015625
▁ther 0.007022857666015625
apy 0.00931549072265625
, 0.0755615234375
▁are 0.09429931640625
▁at 0.409423828125
▁a 0.8388671875
▁higher 0.452880859375
▁risk 0.0010738372802734375
▁of 0.051055908203125
▁developing 0.0751953125
▁breast 0.3701171875
▁cancer 0.005184173583984375
. 0.093017578125
<0x0A> 0.2626953125
Det 10.0546875
ect 1.7783203125
ing 0.035064697265625
▁early 3.21875
▁met 10.6484375
ast 0.024200439453125
asis 1.4111328125
▁is 1.220703125
▁cru 2.71875
cial 0.0013322830200195312
▁in 0.92578125
▁the 0.310302734375
▁treatment 0.7001953125
▁of 0.093017578125
▁breast 0.0830078125
▁cancer 0.003582000732421875
. 0.13720703125
▁Met 2.279296875
ast 0.0007567405700683594
asis 0.138671875
▁occurs 1.46875
▁when 0.01049041748046875
▁cancer 0.420654296875
▁cells 0.041107177734375
▁spread 0.74560546875
▁to 1.228515625
▁other 0.145751953125
▁parts 0.59130859375
▁of 0.0001589059829711914
▁the 0.0007700920104980469
▁body 0.0022716522216796875
, 0.35400390625
▁which 3.74609375
▁can 0.385498046875
▁make 5.5078125
▁the 2.298828125
▁disease 0.865234375
▁much 1.92578125
▁more 0.483154296875
▁difficult 0.1558837890625
▁to 0.006710052490234375
▁treat 0.0836181640625
. 0.041290283203125
▁Reg 7.0546875
ular 0.048492431640625
▁screen 1.625
ings 0.52978515625
, 1.875
▁such 0.3232421875
▁as 0.00019598007202148438
▁m 0.07684326171875
amm 0.0001081228256225586
og 0.25732421875
rams 0.0001380443572998047
▁and 0.61181640625
▁clin 3.20703125
ical 0.0095977783203125
▁breast 0.7685546875
▁ex 0.348388671875
ams 0.00018143653869628906
, 0.01204681396484375
▁can 0.75439453125
▁help 0.35546875
▁detect 0.41259765625
▁early 0.5126953125
▁signs 2.49609375
▁of 0.0233154296875
▁met 0.58837890625
ast 6.902217864990234e-05
asis 0.034393310546875
. 1.6328125
▁These 3.81640625
▁tests 1.9140625
▁allow 3.126953125
▁do 0.6826171875
ctors 1.7881393432617188e-06
▁to 0.0029621124267578125
▁identify 1.6826171875
▁the 2.404296875
▁presence 0.80224609375
▁of 0.007198333740234375
▁any 4.41796875
▁ab 1.3251953125
normal 0.0006551742553710938
▁growth 1.453125
s 0.142578125
▁or 0.97216796875
▁l 1.4345703125
umps 0.0096588134765625
▁in 0.491455078125
▁the 0.1495361328125
▁breast 0.060333251953125
▁t 1.3349609375
issue 0.01251220703125
. 1.486328125
<0x0A> 0.8369140625
Det 5.703125
erm 1.30859375
ining 0.032958984375
▁the 0.464599609375
▁ag 6.53515625
gress 0.00466156005859375
iveness 0.0144805908203125
▁of 0.0203399658203125
▁the 1.2431640625
▁cancer 1.443359375
▁type 8.1328125
▁is 0.1949462890625
▁essential 3.357421875
▁in 0.327392578125
▁developing 4.546875
▁a 0.822265625
▁treatment 0.265625
▁plan 0.050262451171875
. 0.326904296875
▁Do 5.9921875
ctors 0.00045371055603027344
▁use 1.51953125
▁various 2.083984375
▁methods 2.306640625
▁to 0.29296875
▁determine 0.8828125
▁the 0.432861328125
▁stage 2.197265625
▁and 3.970703125
▁grade 1.486328125
▁of 0.01255035400390625
▁breast 2.380859375
▁cancer 0.0137481689453125
, 0.8359375
▁including 0.3974609375
▁imag 2.470703125
ing 0.001766204833984375
▁tests 0.465087890625
, 1.1962890625
▁bi 1.6728515625
ops 0.00945281982421875
ies 0.1292724609375
, 0.031646728515625
▁and 0.07501220703125
▁gen 3.7890625
etic 0.004779815673828125
▁testing 0.45751953125
. 0.00762176513671875
▁Im 6.0
aging 0.00811767578125
▁tests 0.08758544921875
, 0.5869140625
▁such 0.0277099609375
▁as 9.524822235107422e-05
▁M 1.7158203125
RI 0.0240325927734375
▁and 0.56005859375
▁CT 0.654296875
▁sc 0.04541015625
ans 0.006412506103515625
, 0.0064544677734375
▁help 1.94921875
▁do 0.4462890625
ctors 2.9802322387695312e-06
▁assess 3.302734375
▁the 0.27587890625
▁size 0.609375
▁and 0.43701171875
▁location 0.4462890625
▁of 9.334087371826172e-05
▁tum 1.06640625
ors 0.06085205078125
. 0.54736328125
▁Bi 0.445556640625
ops 0.00010788440704345703
ies 0.0283203125
▁involve 4.15625
▁extract 3.595703125
ing 1.6808509826660156e-05
▁a 0.5400390625
▁small 1.1162109375
▁sample 0.32568359375
▁of 0.01270294189453125
▁t 0.64501953125
issue 0.002635955810546875
▁for 2.345703125
▁further 1.041015625
▁exam 1.3486328125
ination 0.0009036064147949219
▁under 1.6201171875
▁a 0.041778564453125
▁mic 0.0036373138427734375
ros 6.9141387939453125e-06
cope 1.7881393432617188e-06
, 3.724609375
▁while 0.8076171875
▁gen 0.08935546875
etic 0.0006308555603027344
▁testing 0.048248291015625
▁can 1.58203125
▁identify 1.5439453125
▁specific 2.27734375
▁gen 0.69287109375
es 1.0244140625
▁or 3.8359375
▁mut 0.6171875
ations 0.0269775390625
▁that 0.31689453125
▁may 1.1904296875
▁affect 3.873046875
▁the 0.380615234375
▁ag 2.783203125
gress 0.006748199462890625
iveness 0.0014410018920898438
▁of 0.0242462158203125
▁the 0.23876953125
▁cancer 0.30859375
. 0.2247314453125
<0x0A> 0.10888671875
In 3.28125
▁conclusion 1.494140625
, 0.002857208251953125
▁understanding 5.47265625
▁the 0.1790771484375
▁critical 5.23046875
▁factors 0.350830078125
▁contrib 3.25
uting 0.00016367435455322266
▁to 0.0015773773193359375
▁the 0.04754638671875
▁development 0.01010894775390625
▁of 0.0260772705078125
▁breast 0.007015228271484375
▁cancer 0.00028133392333984375
, 4.3203125
▁including 1.0224609375
▁her 0.2396240234375
ed 0.0452880859375
ity 0.00016427040100097656
, 0.072021484375
▁dise 0.5185546875
ases 4.0650367736816406e-05
▁of 0.0117034912109375
▁the 0.005313873291015625
▁m 0.0015106201171875
amm 0.0007824897766113281
ary 6.937980651855469e-05
▁g 0.0013952255249023438
lands 0.0069580078125
, 0.03759765625
▁and 0.1033935546875
▁h 0.01123809814453125
orm 8.344650268554688e-07
onal 0.01306915283203125
▁factors 0.0016183853149414062
, 0.08209228515625
▁is 0.453857421875
▁vital 3.103515625
▁for 2.123046875
▁early 4.6640625
▁detection 0.1710205078125
▁and 0.251708984375
▁effective 1.8681640625
▁treatment 0.027313232421875
. 0.1453857421875
▁Det 3.27734375
ect 0.08673095703125
ing 0.0005841255187988281
▁early 0.1151123046875
▁met 0.02593994140625
ast 2.276897430419922e-05
asis 0.0060272216796875
▁and 2.7421875
▁determ 0.1505126953125
ining 4.6253204345703125e-05
▁the 0.00919342041015625
▁ag 0.07257080078125
gress 0.0002486705780029297
iveness 0.0006198883056640625
▁of 0.004764556884765625
▁the 0.08306884765625
▁cancer 0.03326416015625
▁type 0.05987548828125
▁are 0.1600341796875
▁essential 1.7587890625
▁steps 2.794921875
▁in 0.059722900390625
▁ens 6.55078125
uring 5.245208740234375e-06
▁successful 3.158203125
▁out 1.26171875
comes 0.00018286705017089844
▁for 1.1513671875
▁patients 0.84912109375
▁with 2.240234375
▁breast 0.114990234375
▁cancer 0.00025534629821777344
. 0.0068359375
▁A 6.55859375
war 1.044921875
eness 0.0005908012390136719
▁and 1.755859375
▁early 2.275390625
▁diagn 2.37890625
osis 0.0172271728515625
▁are 0.85595703125
▁key 0.88671875
▁in 2.048828125
▁the 1.7626953125
▁fight 0.86865234375
▁against 0.01378631591796875
▁this 1.1044921875
▁disease 0.65625
. 0.176513671875
